Stock DNA
Pharmaceuticals & Biotechnology
JPY 289,964 Million (Small Cap)
NA
0.00%
0.41
-999,999.00%
3.55
Revenue and Profits:
Net Sales:
34,697 Million
(Quarterly Results - Dec 2025)
Net Profit:
7,128 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
82.76%
0%
82.76%
6 Months
115.45%
0%
115.45%
1 Year
87.13%
0%
87.13%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Rigaku Holdings Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
4.96%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
EV to EBIT
EV to EBITDA
EV to Capital Employed
EV to Sales
PEG Ratio
NA
Dividend Yield
ROCE (Latest)
ROE (Latest)
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
34,697.00
18,740.00
85.15%
Operating Profit (PBDIT) excl Other Income
11,886.00
2,309.00
414.77%
Interest
343.00
299.00
14.72%
Exceptional Items
0.00
0.00
Consolidate Net Profit
7,128.00
494.00
1,342.91%
Operating Profit Margin (Excl OI)
303.60%
51.30%
25.23%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 85.15% vs -6.96% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 1,342.91% vs -73.46% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
94,193.00
90,652.00
3.91%
Operating Profit (PBDIT) excl Other Income
22,468.00
23,359.00
-3.81%
Interest
1,143.00
755.00
51.39%
Exceptional Items
0.00
-106.00
100.00%
Consolidate Net Profit
11,401.00
13,615.00
-16.26%
Operating Profit Margin (Excl OI)
184.10%
204.00%
-1.99%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 3.91% vs 13.48% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -16.26% vs 24.86% in Dec 2024






